News and Trends 21 Feb 2017
New Immunotherapy Candidate receives FDA Fast Track Designation
…been designed to facilitate and accelerate the development of drugs which fill a major unmet medical need. It has now been granted to Cell Medica’s lead EBV immunotherapy candidate CMD-003…